ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

IMI offers $70 million to solve key problems

by Alex Scott
May 9, 2016 | APPEARED IN VOLUME 94, ISSUE 19

The European Union’s Innovative Medicines Initiative (IMI) has put out a call for proposals from companies to advance science in the fields of antimicrobial resistance, flu, liver disease, rheumatic disease, and medicines safety. The institute is offering total project funding of $70 million. In the field of antimicrobial resistance, for instance, IMI is seeking greater understanding of the epidemiology and clinical impact of Clostridium difficile infections so that new ways can be developed to prevent and treat them.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment